A detailed history of Y Intercept (Hong Kong) LTD transactions in Mannkind Corp stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 65,622 shares of MNKD stock, worth $449,510. This represents 0.03% of its overall portfolio holdings.

Number of Shares
65,622
Holding current value
$449,510
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$5.01 - $6.7 $328,766 - $439,667
65,622 New
65,622 $412,000
Q1 2024

May 10, 2024

BUY
$3.25 - $5.27 $67,158 - $108,899
20,664 New
20,664 $93,000
Q3 2023

Nov 14, 2023

BUY
$3.91 - $5.45 $82,630 - $115,174
21,133 Added 118.24%
39,006 $161,000
Q2 2023

Aug 14, 2023

BUY
$3.72 - $4.79 $66,487 - $85,611
17,873 New
17,873 $72,000
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $29,819 - $53,023
9,874 Added 59.45%
26,483 $139,000
Q2 2022

Aug 08, 2022

BUY
$2.67 - $4.77 $44,346 - $79,224
16,609 New
16,609 $63,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.76B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.